RT Journal Article SR Electronic T1 Sex-based differences in clearance of chronic Plasmodium falciparum infection JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.06.10.20127720 DO 10.1101/2020.06.10.20127720 A1 Jessica Briggs A1 Noam Teyssier A1 Joaniter I. Nankabirwa A1 John Rek A1 Prasanna Jagannathan A1 Emmanuel Arinatiwe A1 Teun Bousema A1 Chris Drakeley A1 Margaret Murray A1 Emily Crawford A1 Nicholas Hathaway A1 Sarah G. Staedke A1 David Smith A1 Phillip J. Rosenthal A1 Moses Kamya A1 Grant Dorsey A1 Isabel Rodriguez-Barraquer A1 Bryan Greenhouse YR 2020 UL http://medrxiv.org/content/early/2020/09/28/2020.06.10.20127720.abstract AB Multiple studies have reported a male bias in incidence and/or prevalence of malaria infection in males compared to females. To test the hypothesis that sex-based differences in host-parasite interactions affect the epidemiology of malaria, we intensively followed Plasmodium falciparum infections in a cohort in a malaria endemic area of eastern Uganda and estimated both force of infection (FOI) and rate of clearance using amplicon deep-sequencing. We found no evidence of differences in behavioral risk factors, incidence of malaria, or FOI by sex. In contrast, females cleared asymptomatic infections at a faster rate than males (hazard ratio [HR] = 1.82, 95% CI 1.20 to 2.75 by clone and HR = 2.07, 95% CI 1.24 to 3.47 by infection event) in multivariate models adjusted for age, timing of infection onset, and parasite density. These findings implicate biological sex-based differences as an important factor in the host response to this globally important pathogen.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding was provided by the National Institutes of Health as part of the International Centers of Excellence in Malaria Research (ICMER) program (U19AI089674). JB is supported by the National Institutes of Health training grant T32 AI007641-16. JIN is supported by the Fogarty International Center (Emerging Global Leader Award grant number K43TW010365). EA is supported by the Fogarty International Center of the National Institutes of Health under Award Number D43TW010526. The ClinEpiDB platform is supported by award OPP1169785 from the Bill & Melinda Gates Foundation. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study protocol was approved by both the UCSF IRB and the UNCST IRB in Uganda.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available by request from the authors. After acceptance and publication by a peer-reviewed journal, all data will be published on ClinEpiDB.org.